ARA290, a non-erythropoietic EPO derivative, attenuates renal ischemia/reperfusion injury

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1479-5876
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
ARA290, a non-erythropoietic EPO derivative, attenuates renal ischemia/reperfusion injury ; volume:11 ; number:1 ; day:9 ; month:1 ; year:2013 ; pages:1-8 ; date:12.2013
Journal of translational medicine ; 11, Heft 1 (9.1.2013), 1-8, 12.2013

Urheber
van Rijt, Willem G.
Beteiligte Personen und Organisationen
Nieuwenhuijs-Moeke, Gertrude J.
van Goor, Harry
Jespersen, Bente
Ottens, Petra J.
Ploeg, Rutger J.
Leuvenink, Henri GD
SpringerLink (Online service)

DOI
10.1186/1479-5876-11-9
URN
urn:nbn:de:1111-2016041444119
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:56 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • van Rijt, Willem G.
  • Nieuwenhuijs-Moeke, Gertrude J.
  • van Goor, Harry
  • Jespersen, Bente
  • Ottens, Petra J.
  • Ploeg, Rutger J.
  • Leuvenink, Henri GD
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Renoprotective capacities of non-erythropoietic EPO derivative, ARA290, following renal ischemia/reperfusion injury

Renoprotective capacities of non-erythropoietic EPO derivative, ARA290, following renal ischemia/reperfusion injury

Vanillic acid attenuates testicular ischemia/reperfusion injury in rats

Vanillic acid attenuates testicular ischemia/reperfusion injury in rats

Saikosaponin A attenuates neural injury caused by ischemia/reperfusion

Saikosaponin A attenuates neural injury caused by ischemia/reperfusion

Diminazene aceturate attenuates hepatic ischemia/reperfusion injury in mice

Diminazene aceturate attenuates hepatic ischemia/reperfusion injury in mice

Pretreatment of parecoxib attenuates hepatic ischemia/reperfusion injury in rats

Pretreatment of parecoxib attenuates hepatic ischemia/reperfusion injury in rats

Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis

Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis

Deferoxamine attenuates visual impairment in retinal ischemia‒reperfusion via inhibiting ferroptosis

Deferoxamine attenuates visual impairment in retinal ischemia‒reperfusion via inhibiting ferroptosis

Thymoquinone Attenuates Myocardial Ischemia/Reperfusion Injury Through Activation of SIRT1 Signaling

Thymoquinone Attenuates Myocardial Ischemia/Reperfusion Injury Through Activation of SIRT1 Signaling

Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation

Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation

Hydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation

Hydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation

Naringin attenuates cerebral ischemia-reperfusion injury in rats by inhibiting endoplasmic reticulum stress

Naringin attenuates cerebral ischemia-reperfusion injury in rats by inhibiting endoplasmic reticulum stress

The novel nitric oxide donor PDNO attenuates ovine ischemia-reperfusion induced renal failure

The novel nitric oxide donor PDNO attenuates ovine ischemia-reperfusion induced renal failure

Verbundene Objekte